Florin Despa

Targeting the pancreas to treat Alzheimer’s disease

Diabetes-associated cognitive dysfunction

Systemic inflammation and reduced cerebral Aβ clearance triggered by pancreatic amylin

What underlies the increased risk of dementia in patients with type 2 diabetes?

Hyperamylinemia in early type-2 diabetes blocks Aβ elimination in the Alzheimer’s disease brain